Vaishali Pharma balance sheet

·UnclassifiedChart ›

As of Mar 2026

Total assets: ₹123cr+12.3% on Mar 2025
Shareholders' equity: ₹69.1cr+6.5% on Mar 2025
Total debt: ₹18.5cr+58.9% on Mar 2025
Cash and investments: ₹1.1cr−35.2% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Non-current assets
	0.9	1.2	1.5	1.8
	0.8	0.7	—	0.2
	0.2	—	0.7	0.7
	5.6	—	—	—
	2.0	1.9	1.9	2.3
	7.6	2.4	2.3	2.7
	0.2	—	—	—
	0.7	0.7	0.7	0.7
	10.4	5.4	5.4	6.2
Current assets
	3.4	4.8	—	3.1
	50.8	46.7	49.4	53.6
	1.1	1.7	1.5	0.5
	0.3	0.1	0.1	0.5
	32.1	28.3	12.0	11.4
	84.3	76.8	63.0	66.0
	24.9	22.8	11.0	—
	113	104	74.5	72.7
	123	110	80.0	78.9
Equity
	26.1	26.1	10.7	10.5
	43.0	38.8	32.1	30.0
	69.1	64.9	42.8	40.5
	69.1	64.9	42.8	40.5
Liabilities
	5.7	4.2	3.6	5.2
	5.7	4.2	3.6	5.2
	0.3	0.3	0.2	0.2
	6.0	4.9	4.0	6.3
	12.8	7.5	9.0	8.4
	21.2	—	19.4	18.0
	0.6	0.3	0.3	0.3
	34.6	—	28.7	—
	0.3	—	0.0	0.0
	13.4	4.9	3.7	3.1
	48.3	40.1	33.1	32.1
	54.3	44.9	37.1	38.4
	123	110	80.0	78.9
Assets — additional as-filed lines
	0.3	—	—	—
Trade payables — MSME split
	2.7	—	—	—
	18.5	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VAISHALI₹6.82

Vaishali Pharma Limited

· Unclassified

₹ CrorePeersTEMBO TOTAL OSWALSEEDS GROBTEA BEARDSELL HINDCON CROWN ARTNIRMANMcap ₹44.5 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1.8	1.5	1.2	0.9	0.9
+ Other Intangibles	0.2	—	0.7	0.8	0.8
+ Intangibles under Development	0.7	0.7	—	0.2	0.2
+ Non-current Investments	—	—	—	5.6	5.6
+ Other Non-current Financial Assets	2.3	1.9	1.9	2.0	2.0
Non-current Financial Assets	2.7	2.3	2.4	7.6	7.6
+ Deferred Tax Assets	—	—	—	0.2	0.2
+ Other Non-current Assets	0.7	0.7	0.7	0.7	0.7
Total Non-current Assets	6.2	5.4	5.4	10.4	10.4
Current Assets
+ Inventories	3.1	—	4.8	3.4	3.4
+ Trade Receivables	53.6	49.4	46.7	50.8	50.8
+ Cash & Cash Equivalents	0.5	1.5	1.7	1.1	1.1
+ Other Bank Balances	0.5	0.1	0.1	0.3	0.3
+ Other Current Financial Assets	11.4	12.0	28.3	32.1	32.1
Current Financial Assets	66.0	63.0	76.8	84.3	84.3
+ Other Current Assets	—	11.0	22.8	24.9	24.9
Total Current Assets	72.7	74.5	104.5	113.0	113.0
Total Assets	78.9	80.0	109.8	123.4	123.4
Equity
+ Equity Share Capital	10.5	10.7	26.1	26.1	26.1
+ Other Equity / Reserves	30.0	32.1	38.8	43.0	43.0
Equity — Owners of Parent	40.5	42.8	64.9	69.1	69.1
Total Equity	40.5	42.8	64.9	69.1	69.1
Liabilities
+ Borrowings — Non-current	5.2	3.6	4.2	5.7	5.7
Non-current Financial Liabilities	5.2	3.6	4.2	5.7	5.7
+ Provisions — Non-current	0.2	0.2	0.3	0.3	0.3
Non-current Liabilities	6.3	4.0	4.9	6.0	6.0
+ Borrowings — Current	8.4	9.0	7.5	12.8	12.8
+ Trade Payables	18.0	19.4	—	21.2	21.2
+ Other Current Financial Liab	0.3	0.3	0.3	0.6	0.6
Current Financial Liabilities	—	28.7	—	34.6	34.6
+ Provisions — Current	0.0	0.0	—	0.3	0.3
+ Other Current Liabilities	3.1	3.7	4.9	13.4	13.4
Current Liabilities	32.1	33.1	40.1	48.3	48.3
Total Liabilities	38.4	37.1	44.9	54.3	54.3
Total Equity & Liabilities	78.9	80.0	109.8	123.4	123.4
Assets — additional as-filed lines
+ Current Tax Assets	—	—	—	0.3	0.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	—	2.7	2.7
+ Dues to Other Creditors — Current	—	—	—	18.5	18.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.